Adaptive Design - Recent Advancement in Clinical Trials

Abstract

In the past decade, the pharmaceutical industry experienced a paradigm shift from classical to adaptive clinical trial design. The high NDA failure rate and the increasing cost in pharmaceutical R & D is the motivation behind the innovation. Biostatisticians in collaboration with physicians and other major stockholders in pharmaceutical R & D are the… (More)

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Chang2016AdaptiveD, title={Adaptive Design - Recent Advancement in Clinical Trials}, author={Mark Chang and John Balser}, year={2016} }